A detailed history of Sovereign Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sovereign Investment Advisors, LLC holds 5,215 shares of BMY stock, worth $291,153. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,215
Holding current value
$291,153
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$51.92 - $59.94 $270,762 - $312,587
5,215 New
5,215 $294,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sovereign Investment Advisors, LLC Portfolio

Follow Sovereign Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sovereign Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sovereign Investment Advisors, LLC with notifications on news.